Hollie Milton
PhD student
Research interests
- Host-Microbiome Interactions
Contact details
Biography
Hollie Milton joined the Translational Research and Innovation in Microbial Sciences (TRIMS) Doctoral Training Programme in 2026, and is now working between the Garnett Lab and the Wu Lab at the Rosalind Franklin Institute studying the structural and functional aspects of Legionella Collagen-like (Lcl) Protein in Legionella pneumophila host-cell infection.
Hollie obtained her BSc and MRes qualifications in Biomedical Science from Cardiff Metropolitan University, during which she researched Mycoplasma spp. in the Beeton Lab. Her MRes studies included focuses on genetic and phenotypic variation of antibiotic-resistant Mycoplasma pneumoniae and surveillance of macrolide resistant M. pneumoniae across Wales.
Research
Garnett Lab
The Garnett Lab investigates molecular mechanisms that promote bacterial disease. In particular we are interested in biofilm formation and other key virulence traits that allow bacteria to establish infections and persist within the host/environment.
Centre for Host-Microbiome Interactions
Millions of microorganisms live in and on our bodies forming microbiomes on different surfaces. Researchers in the Centre for Host Microbiome Interactions study our relationship with these bacteria and fungi in health or in oral and systemic diseases such as periodontitis, candidiasis, oral cancer and Alzheimer’s disease.
Research
Garnett Lab
The Garnett Lab investigates molecular mechanisms that promote bacterial disease. In particular we are interested in biofilm formation and other key virulence traits that allow bacteria to establish infections and persist within the host/environment.
Centre for Host-Microbiome Interactions
Millions of microorganisms live in and on our bodies forming microbiomes on different surfaces. Researchers in the Centre for Host Microbiome Interactions study our relationship with these bacteria and fungi in health or in oral and systemic diseases such as periodontitis, candidiasis, oral cancer and Alzheimer’s disease.